When did GLOBUS MEDICAL INC - A (GMED) report earnings last quarter?
GLOBUS MEDICAL INC - A (GMED) last reported earnings on 2/24/2026.
GLOBUS MEDICAL INC - A (GMED) Earnings History & Surprises
NYSE:GMED • US3795772082
Current stock price
90 USD
+1.4 (+1.58%)
At close:
90 USD
0 (0%)
After Hours:
GMED Earnings overview
Past quarterly earnings results for GLOBUS MEDICAL INC - A (GMED), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 1, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.94
- Revenue Estimate
- 751.74M
Last Reported
Most Recent- Release Date
- Feb 24, 2026
- Period
- Q4 / 2025
- EPS Reported
- $1.28
- EPS Surprise
- 9.18%
- Revenue Surprise
- 1.39%
Beat Rate
Last 8 Quarters 81%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.28 | 1.17 | 9.18% | 52.38% | 826.42M | 815.11M | 1.39% | 25.73% |
| Q3 2025 | 1.18 | 0.80 | 47.79% | 42.17% | 769.048M | 749.03M | 2.67% | 22.91% |
| Q2 2025 | 0.86 | 0.77 | 11.60% | 14.67% | 745.342M | 756.65M | -1.49% | 18.37% |
| Q1 2025 | 0.68 | 0.76 | -10.39% | -5.56% | 598.121M | 638.42M | -6.31% | -1.41% |
| Q4 2024 | 0.84 | 0.76 | 10.48% | 40.00% | 657.293M | 656.24M | 0.16% | 6.61% |
| Q3 2024 | 0.83 | 0.66 | 25.45% | 45.61% | 625.705M | 616.01M | 1.57% | 63.10% |
| Q2 2024 | 0.75 | 0.69 | 8.60% | 19.05% | 629.691M | 627.65M | 0.33% | 115.93% |
| Q1 2024 | 0.72 | 0.58 | 24.38% | 35.85% | 606.666M | 598.88M | 1.30% | 119.26% |
| Q4 2023 | 0.60 | 0.62 | -3.57% | 1.69% | 616.534M | 620.2M | -0.59% | 124.60% |
| Q3 2023 | 0.57 | 0.58 | -2.25% | 14.00% | 383.639M | 435.83M | -11.98% | 50.98% |
| Q2 2023 | 0.63 | 0.61 | 4.09% | 12.50% | 291.615M | 285.32M | 2.21% | 10.63% |
| Q1 2023 | 0.53 | 0.52 | 2.20% | 26.19% | 276.688M | 260.39M | 6.26% | 20.04% |
| Q4 2022 | 0.59 | 0.57 | 3.24% | 20.41% | 274.5M | 282.2M | -2.73% | 9.80% |
| Q3 2022 | 0.50 | 0.53 | -5.77% | - | 254.1M | 258.21M | -1.59% | 10.62% |
| Q2 2022 | 0.56 | 0.54 | 2.86% | - | 263.6M | 264.58M | -0.37% | 5.02% |
| Q1 2022 | 0.42 | 0.48 | -11.98% | -14.29% | 230.5M | 238.85M | -3.50% | 1.41% |
| Q4 2021 | 0.49 | 0.48 | 1.69% | -15.52% | 250M | 248.39M | 0.65% | 7.11% |
| Q3 2021 | 0.50 | 0.46 | 8.54% | 2.04% | 229.7M | 232.87M | -1.36% | 6.29% |
| Q2 2021 | 0.56 | 0.45 | 23.57% | 700.00% | 251M | 229.98M | 9.14% | 68.57% |
| Q1 2021 | 0.49 | 0.37 | 30.88% | 68.97% | 227.3M | 202.36M | 12.32% | 19.25% |
| Q4 2020 | 0.58 | 0.52 | 11.85% | - | 233.4M | 235.84M | -1.03% | - |
| Q3 2020 | 0.49 | 0.31 | 58.93% | - | 216.1M | 200.05M | 8.02% | - |
| Q2 2020 | 0.07 | -0.11 | 164.34% | - | 148.9M | 101.72M | 46.38% | - |
| Q1 2020 | 0.29 | 0.39 | -25.75% | - | 190.6M | 198.39M | -3.93% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
14.55%
Max EPS beat (4)
47.79%
Min EPS beat (4)
-10.39%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
-0.94%
Max Revenue beat (4)
2.67%
Min Revenue beat (4)
-6.31%
Analysis
In the last 4 quarters, GMED has beaten EPS estimates in 3 out of 4 releases
GMED has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, GMED has beaten the EPS estimates by 14.5% on average.
In the last 4 quarters, GMED reported -0.9% below the revenue estimates on average.
Related analysis
GLOBUS MEDICAL INC - A / GMED Earnings FAQ
Did GLOBUS MEDICAL INC - A (GMED) beat earnings estimates last quarter?
GLOBUS MEDICAL INC - A (GMED) beat EPS estimates and beat revenue estimates in the most recent quarter.
What percentage of the time does GMED stock beat earnings estimates?
In the last 4 quarters, GLOBUS MEDICAL INC - A (GMED) has beaten EPS estimates in 3 out of 4 releases.